| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.1M | +0.0% |
| R&D Expense | $12.8M | -65.7% |
| SG&A Expense | $10.8M | -9.6% |
| Operating Income | -$23.6M | -185.8% |
| Pre-tax Income | -$22.4M | -190.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$22.4M | -177.6% |
| EPS (Basic) | -$0.39 | -69.6% |
| EPS (Diluted) | -$0.39 | -69.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.3M | +67.4% |
| Current Assets | $31.0M | +24.3% |
| Total Assets | $31.9M | +24.5% |
| Current Liabilities | $2.9M | -53.8% |
| Total Liabilities | $3.3M | -49.7% |
| Stockholders' Equity | $28.6M | +50.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.7M | -19.6% |
| Capital Expenditures | $48K | -43.5% |
| Investing Cash Flow | $4.5M | -67.7% |
| Financing Cash Flow | $30.4M | — |
| Free Cash Flow | -$22.8M | -19.3% |